These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 9072584)

  • 1. Testosterone supplementation for hypogonadal impotence: assessment of biochemical measures and therapeutic outcomes.
    Morales A; Johnston B; Heaton JP; Lundie M
    J Urol; 1997 Mar; 157(3):849-54. PubMed ID: 9072584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral androgens in the treatment of hypogonadal impotent men.
    Morales A; Johnston B; Heaton JW; Clark A
    J Urol; 1994 Oct; 152(4):1115-8. PubMed ID: 8072077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of testosterone supplementation on sexual function in hypogonadal men with erectile dysfunction.
    Mulhall JP; Valenzuela R; Aviv N; Parker M
    Urology; 2004 Feb; 63(2):348-52; discussion 352-3. PubMed ID: 14972487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of sexual function in men with late-onset hypogonadism treated with testosterone only.
    Yassin AA; Saad F
    J Sex Med; 2007 Mar; 4(2):497-501. PubMed ID: 17367445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subjective sexual response to testosterone replacement therapy based on initial serum levels of total testosterone.
    Reyes-Vallejo L; Lazarou S; Morgentaler A
    J Sex Med; 2007 Nov; 4(6):1757-62. PubMed ID: 17087806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testosterone replacement: when is there a role?
    Morales A
    Int J Impot Res; 2000 Oct; 12 Suppl 4():S112-8. PubMed ID: 11035397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of testosterone supplementation on symptoms in men with hypogonadism.
    Ramasamy R; Wilken N; Scovell JM; Lipshultz LI
    Eur Urol; 2015 Jan; 67(1):176-177. PubMed ID: 25199721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved sexual function with testosterone replacement therapy in hypogonadal men: real-world data from the Testim Registry in the United States (TRiUS).
    Khera M; Bhattacharya RK; Blick G; Kushner H; Nguyen D; Miner MM
    J Sex Med; 2011 Nov; 8(11):3204-13. PubMed ID: 21834870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of sexual dysfunction of hypogonadal patients with long-acting testosterone undecanoate (Nebido).
    Yassin AA; Saad F
    World J Urol; 2006 Dec; 24(6):639-44. PubMed ID: 17048032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of androgen treatment in impotent men with normal and low levels of free testosterone.
    Carani C; Zini D; Baldini A; Della Casa L; Ghizzani A; Marrama P
    Arch Sex Behav; 1990 Jun; 19(3):223-34. PubMed ID: 2193636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined testosterone and vardenafil treatment for restoring erectile function in hypogonadal patients who failed to respond to testosterone therapy alone.
    Yassin DJ; Yassin AA; Hammerer PG
    J Sex Med; 2014 Feb; 11(2):543-52. PubMed ID: 24251448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IPASS: a study on the tolerability and effectiveness of injectable testosterone undecanoate for the treatment of male hypogonadism in a worldwide sample of 1,438 men.
    Zitzmann M; Mattern A; Hanisch J; Gooren L; Jones H; Maggi M
    J Sex Med; 2013 Feb; 10(2):579-88. PubMed ID: 22812645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intramuscular injection of testosterone undecanoate for the treatment of male hypogonadism: phase I studies.
    Behre HM; Abshagen K; Oettel M; Hübler D; Nieschlag E
    Eur J Endocrinol; 1999 May; 140(5):414-9. PubMed ID: 10229906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An exploratory study of the effects of 12 month administration of the novel long-acting testosterone undecanoate on measures of sexual function and the metabolic syndrome.
    Saad F; Gooren L; Haider A; Yassin A
    Arch Androl; 2007; 53(6):353-7. PubMed ID: 18357966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypogonadal men treated with oral testosterone undecanoate.
    Sarris S; Swyer GI; Lawrence DM
    Acta Eur Fertil; 1977 Dec; 8(4):297-9. PubMed ID: 610314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long acting testosterone undecanoate therapy in men with hypogonadism: results of a pharmacokinetic clinical study.
    Morgentaler A; Dobs AS; Kaufman JM; Miner MM; Shabsigh R; Swerdloff RS; Wang C
    J Urol; 2008 Dec; 180(6):2307-13. PubMed ID: 18930255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re: Oral androgens in the treatment of hypogonadal impotent men.
    Loughlin KR; O'Leary MP
    J Urol; 1995 May; 153(5):1645. PubMed ID: 7755797
    [No Abstract]   [Full Text] [Related]  

  • 18. Combined use of androgen and sildenafil for hypogonadal patients unresponsive to sildenafil alone.
    Hwang TI; Chen HE; Tsai TF; Lin YC
    Int J Impot Res; 2006; 18(4):400-4. PubMed ID: 16395321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demographic and Clinical Correlates of Patient-Reported Improvement in Sex Drive, Erectile Function, and Energy With Testosterone Solution 2.
    Wu F; Zitzmann M; Heiselman D; Donatucci C; Knorr J; Patel AB; Kinchen K
    J Sex Med; 2016 Aug; 13(8):1212-9. PubMed ID: 27329542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testosterone therapy improves erectile function and libido in hypogonadal men.
    Rizk PJ; Kohn TP; Pastuszak AW; Khera M
    Curr Opin Urol; 2017 Nov; 27(6):511-515. PubMed ID: 28816715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.